About quantal squander

What is quantal squander?

Acquired neuromyotonia is an inflammatory disorder characterized by abnormal nerve impulses from the peripheral nerves that result in continuous muscle fiber activity. Affected individuals often experience progressive muscle stiffness and cramping especially in the hands and feet, increased sweating, and delayed muscle relaxation. Symptoms may persist even during sleep or under general anesthesia.

What are the symptoms for quantal squander?

Muscle fasciculation symptom was found in the quantal squander condition

Symptoms include progressive muscle stiffness; continuously contracting or twitching muscles (myokymia); and diminished reflexes.

What are the causes for quantal squander?

Quantal squander or Issac’s syndrome is a rare neuromuscular condition. Hyperexcitability and persistent firing of the peripheral nerve axons responsible for the activation of muscle fibers is the main cause.

Treatments
Intravenous immunoglobulin is a solution that contains antibodies from the donors
Plasma exchange helps to filter toxins and unhealthy antibodies out of the blood stream

Causes
Autoimmune conditions
It could be genetic

Symptoms
Bleeding through the skin,Bleeding in mucus membranes,Anemia,Fatigue,Weakness,Confusion,Fever,Strokes,Seizures,Headaches,Shortness of breath,Rapid heart rate,Jaundice
Conditions
Blood clots
Drugs
Rituximab,Glucocorticoids

What are the treatments for quantal squander?

Quantal squander is a rare neuromuscular disorder of continuous muscle fiber activity caused by the hyperexcitability of peripheral neurons. The disease is also known as Isaac syndrome, neuromyotonia, and Isaac-Mertens syndrome. It is most prevalent in the age group of 40 to 60. The characteristic clinical manifestations include muscle twitching at rest, stiffness, cramps, and myokymia. It is either genetic in origin or acquired. Recently, its association with autoimmune disorders has been frequently reported.

Treatment
There is no standard treatment consensus for Isaac's disease. Commonly interventions depend on symptoms and severity. The common treatment options are:
1. Anticonvulsants such as gabapentin, sodium valproate, phenytoin, carbamazapine, lamotrigine, and acetazolamide. Most anticonvulsants have adverse effects on fetus in patients during pregnancy.
2. When a patient does not respond to anticonvulsants, prednisolone is an alternative in mild cases. 3. The following options may be necessary for severe cases.

  • Plasma exchange
  • Immunosuppressive agents such as azathioprine and methotrexate
  • Immunoglobulin therapy refers to the infusion of immunoglobulins against causative antibodies from a donor.
4. Few reports show the varying effect of anesthetic management on patients. Lumbar epidural anesthesia with 2% carbocaine has effectively reduced myokymic discharges.

Symptoms
Pseudomyotonia (delayed relaxation followed by contraction),Muscle fasciculation,Myokymia (continuous slow contractions in small muscles),Muscle cramps, and stiffness,Patients may also present muscle weakness, distal sensory impairment, hyperhidrosis (increased sweating), and weight loss
Conditions
Peripheral nerve hyperexcitability
Drugs
Anticonvulsants such as gabapentin,Sodium valproate,Phenytoin,Carbamazapine,Lamotrigine,Acetazolamide,Corticosteroids such as prednisolone,Immunosuppressive agents such as methotrexate and azathioprine
carbocaine

What are the risk factors for quantal squander?

Quantal squander syndrome, also known as Isaac syndrome, is a rare neuromuscular disorder caused by continuous muscle fiber activity due to peripheral nerve hyperactivity. It is either inherited or acquired. The disease can occur in any age group, with the peak in the age group of 40 to 60. Characteristic symptoms are pseudomyotonia, myokymia, muscle cramps, and stiffness. Patients may also present muscle weakness, distal sensory impairment, hyperhidrosis, and weight loss. The principal diagnosis is needle electromyography, which helps detect myokymia and neuromyotonia activities.
Risk factors
The exact cause of quantal squander is yet to be known. However, the genetic root has been associated with episodic ataxia type 1, a point mutation in the KCNA 1 gene that encodes for the synthesis of voltage-gated potassium channel subunit. The mutation is autosomal dominant, and the familial history of the disease is a risk factor for inherited quantal squander.

The risk factors for acquired neuromyotonia are
1. Autoimmune disorders, such as myasthenia gravis, Lambert-Eaton myasthenic syndrome, Hashimoto thyroiditis, Addison disease, vitiligo, vitamin B12 deficiency, coeliac disease, rheumatoid arthritis, and Guillain-Barre syndrome.
2. Infections
3. Drugs such as penicillamine
4. Exposure to toxins
5. Pregnancy
6. Cancers such as thymoma and small-cell lung cancer

Symptoms
Pseudomyotonia (delayed relaxation followed by contraction),Muscle fasciculation,Myokymia (continuous slow contractions in small muscles),Muscle cramps, and stiffness,Patients may also present muscle weakness, distal sensory impairment, hyperhidrosis (increased sweating), and weight loss
Conditions
Peripheral nerve hyperexcitability
Drugs
Anticonvulsants such as gabapentin,Sodium valproate,Phenytoin,Carbamazapine,Lamotrigine,Acetazolamide,Corticosteroids such as prednisolone,Immunosuppressive agents such as methotrexate and azathioprine
carbocaine

Is there a cure/medications for quantal squander?

Quantal squander syndrome is a rare yet treatable neuromuscular disorder caused by hyperexcitability of peripheral nerves. The other names for the disease are Isaac syndrome, neuromyotonia, and Isaac-Mertens syndrome. Inherited form results from a point mutation in the KCNA 1 gene that encodes for the synthesis of voltage-gated potassium channel subunit. The acquired form is attributed to autoimmune disorders, infections, exposure to toxins, and cancers. Characteristic features of the disease are muscle twitching, spasms, stiffness, and delayed relaxation after contraction.

Cure/medication
There is no consensus on the treatment of neuromyotonia. However, the disease is still curable with, sometimes, highly individualized modalities.
1. The first-line treatment is anticonvulsants, including phenytoin, carbamazepine, gabapentin, sodium valproate, lamotrigine, and acetazolamide. Patients during pregnancy should avoid medications that offer adverse effects on fetal development.
2. Corticosteroids such as prednisolone are an alternative for patients who do not respond to anticonvulsants.
3. Patients with a severe form of the disease may need one of the following treatments:
4. Immunoglobulin therapy involves the transfusion of immunoglobulins from a donor to neutralize autoantibodies.
5. Plasma exchange therapy
5. Immunosuppressive agents such as methotrexate and azathioprine.
A study demonstrates varying results of lumbar epidural anesthetic management with 2% carbocaine to reduce myokymic discharges.

Symptoms
Pseudomyotonia (delayed relaxation followed by contraction),Muscle fasciculation,Myokymia (continuous slow contractions in small muscles),Muscle cramps, and stiffness,Patients may also present muscle weakness, distal sensory impairment, hyperhidrosis (increased sweating), and weight loss
Conditions
Peripheral nerve hyperexcitability
Drugs
Anticonvulsants such as gabapentin,Sodium valproate,Phenytoin,Carbamazapine,Lamotrigine,Acetazolamide,Corticosteroids such as prednisolone,Immunosuppressive agents such as methotrexate and azathioprine
carbocaine

Video related to quantal squander